Edition:
India

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

94.97USD
1:32am IST
Change (% chg)

$0.44 (+0.47%)
Prev Close
$94.53
Open
$95.08
Day's High
$95.38
Day's Low
$94.13
Volume
352,632
Avg. Vol
383,684
52-wk High
$112.00
52-wk Low
$62.69

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company manufactures heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. It develops hemodynamic monitoring systems used to measure a... (more)

Overall

Beta: 0.59
Market Cap(Mil.): $20,017.93
Shares Outstanding(Mil.): 211.76
Dividend: --
Yield (%): --

Financials

UPDATE 2-Edwards raises outlook, plans for valve label expansion

April 26 Edwards Lifesciences Corp on Tuesday raised its full-year sales and profit outlook following strong first-quarter results and said approval for expanded use of its minimally invasive heart valve implant could come sooner than previously expected.

27 Apr 2016

Edwards CEO says aims for early Q4 launch of valve for new patient group

April 26 EDWARDS LIFESCIENCES CEO SAYS PLANNING FOR FDA APPROVAL, LAUNCH OF TAVR FOR INTERMEDIATE-RISK PATIENTS AT BEGINNING OF Q4 EDWARDS CEO SAYS APPROVAL COULD COME SOONER DUE TO STRENGTH OF STUDY DATA, BUT HARD TO PREDICT REGULATORY TIMELINES EDWARDS CEO SAYS COMPANY ON TRACK TO SUBMIT FINAL DATA SETS FOR INTERMEDIATE-RISK PATIENTS TO FDA IN NEXT COUPLE OF WEEKS (Reporting by Susan Kelly in Chicago)

27 Apr 2016

BRIEF-Edwards Lifesciences Q1 adj shr $0.71

* Q1 earnings per share view $0.66 -- Thomson Reuters I/B/E/S

27 Apr 2016

BRIEF-Edwards lifesciences Q1 THVT sales up 37 pct to $367.8 mln

* Edwards Lifesciences says 2016 THVT sales guidance raised to $1.4 - $1.6 bln

27 Apr 2016

Edwards Lifesciences raises outlook on strong valve sales

April 26 Edwards Lifesciences Corp on Tuesday reported a better-than-expected quarterly profit and raised its full-year outlook on strong sales of its minimally invasive heart valve implants.

27 Apr 2016

US STOCKS-Wall St flat as investors take stock after rally

* Indexes down: Dow 0.06 pct, S&P 0.11 pct, Nasdaq 0.13 pct (Updates to early afternoon)

04 Apr 2016

US STOCKS-Wall St flat as investors pause after rally

* Indexes down: Dow 0.27 pct, S&P 0.30 pct, Nasdaq 0.39 pct (Adds details, changes comment, updates prices)

04 Apr 2016

US STOCKS-Wall St little changed as oil dips, health stocks rise

* Indexes down: Dow 0.13 pct, S&P 0.1 pct, Nasdaq 0.09 pct (Updates to open)

04 Apr 2016

US STOCKS-Wall St set for slightly higher open

* Futures up: Dow 10 pts, S&P 3 pts, Nasdaq 5.25 pts (Adds details, comment, updates prices)

04 Apr 2016

BRIEF-Edwards Lifesciences CEO's 2015 total compensation was $9.1 mln vs $8.6 mln in 2014 - SEC Filing

* Says CEO Michael Mussallem's 2015 total compensation was $9.1 million versus $8.6 million in 2014 - sec filing Source text for Eikon: (http://1.usa.gov/1SpQhLv) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

01 Apr 2016

Earnings vs. Estimates